Novanta (NOVTU) Cost of Revenue (2016 - 2025)
Historic Cost of Revenue for Novanta (NOVTU) over the last 17 years, with Q3 2025 value amounting to $136.9 million.
- Novanta's Cost of Revenue rose 127.6% to $136.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $530.1 million, marking a year-over-year increase of 335.09%. This contributed to the annual value of $527.7 million for FY2024, which is 953.47% up from last year.
- Novanta's Cost of Revenue amounted to $136.9 million in Q3 2025, which was up 127.6% from $134.3 million recorded in Q2 2025.
- Novanta's Cost of Revenue's 5-year high stood at $136.9 million during Q3 2025, with a 5-year trough of $93.8 million in Q2 2021.
- In the last 5 years, Novanta's Cost of Revenue had a median value of $123.8 million in 2022 and averaged $121.0 million.
- As far as peak fluctuations go, Novanta's Cost of Revenue skyrocketed by 3618.67% in 2021, and later tumbled by 711.94% in 2023.
- Over the past 5 years, Novanta's Cost of Revenue (Quarter) stood at $116.1 million in 2021, then grew by 6.68% to $123.8 million in 2022, then fell by 7.12% to $115.0 million in 2023, then grew by 12.89% to $129.8 million in 2024, then increased by 5.45% to $136.9 million in 2025.
- Its last three reported values are $136.9 million in Q3 2025, $134.3 million for Q2 2025, and $129.0 million during Q1 2025.